BioSpace News Archive

Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announced that it will present its second-quarter 2022 financial results on August 10 at 8.30 a.m. EDT.

Adicet Bio, Inc., a clinical-stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer, announced it granted inducement awards on July 29, 2022 under Adicet’s 2022 Inducement Plan as a material inducement to employment to seven individuals hired by Adicet in July 2022.

The American Cancer Society, a global organization leading the fight for a world without cancer, held their inaugural Diversity, Equity & Inclusion Impact Makers event on June 23, 2022, in Chicago, IL.

, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities.

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on July 29, 2022 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to 28 individuals hired by Sarepta in July 2022.